September 16, 2026

"Biosynthesis" is upgrading the tablet production site for 350 million rubles

Pharma

Penza "Biosynthesis" will invest 350 million rubles in the modernization of the tablet production site and create 35 jobs.

Penza Pharmaceutical Company PJSC "Biosynthesis" is completing work on the reconstruction of the production site for tablet dosage forms. According to the regional government, investments in the modernization of the facility will amount to 350 million rubles, and the launch of the new site will create 35 jobs.Preparations for the launch are currently underway at the reconstructed site. The production site is equipped with modern equipment for the production of medicines, which will increase the production capacity of the enterprise.

"Investments in modernization create conditions for the further development of the enterprise. Serious funds have been invested in the modernization of production, which makes it possible to predict that "Biosynthesis" will continue to develop steadily," said Oleg Melnichenko, Governor of the Penza Region.

On September 7, the head of the region visited the reconstructed site. According to him, the company is going through a period of active growth and capacity renewal.

New technologies will allow "Biosynthesis" to increase the production of medicines, including:

  • drugs from the list of vital and essential medicines (VED);
  • drugs intended to replace demanded imported analogues.

Today "Biosynthesis" produces more than 127 names of medicines, including antibiotics, drugs for the treatment of diseases of the cardiovascular system, gastrointestinal tract and nervous system. The plant's portfolio includes solutions for infusions and injections, ointments and gels, tablets and capsules.

""After the inspection of the production, a working meeting was held, which was attended by Governor Oleg Melnichenko, CEO of PJSC "Biosynthesis" Dmitry Boldov, Head of the group of companies "Sun Pharma" in Eurasia Artur Valiev and CEO of the Association of Russian Pharmaceutical Manufacturers (ARFP) Victor Dmitriev. The participants discussed the prospects for further development of the company.

"Biosynthesis" is one of the largest Russian manufacturers of vital drugs and is one of the key pharmaceutical companies in the Volga Federal District. The modernization of production facilities is part of the company's long—term strategy aimed at strengthening drug safety and import substitution in the pharmaceutical industry.

 

 

Source: Pharmprom

Latest posts by email:
To subscribe to the newsletter, first Come in Either Register

Other news

Pharma

In today’s world, effective resource management is becoming an increasingly crucial aspect of successful business operations. This is especially true for industries where equipment plays a key role—such as pharmaceuticals, cosmetology, and the food industry.

02.10.2025
Pharma

A new administrative and production-warehouse complex of the pharmaceutical enterprise Farmstandart-UfaVITA has been commissioned in the center of Ufa. Investment exceeded 10 billion rubles, and new production lines are designed to produce 75 million medicine packages per year.

06.10.2026
Pharma

A Russian drugmaker, with the support of integrator IST-PAK, deployed an Italian SIEMPHARMA SRL counting-filling line for packaging tablets and capsules into plastic jars. The project was delivered despite a constrained shop floor and a fixed budget.

02.10.2026
Pharma

Farmasyntez Group commissioned a new pharmaceutical enterprise in Ussuriysk (Primorsky Krai). The plant with a design capacity of 12 million medicine packages a year was implemented under the import substitution program Pharma-2030; 90% of manufactured items are on the VED list.

01.10.2026
Pharma

Argumentum Pharma is completing the equipping of its new pharmaceutical plant in Moscow region's Dubna SEZ: high-tech automated filling and packaging lines have already been installed. Total investment in the project is estimated at 2.5 billion rubles, with commissioning planned before the end of 2026.

29.09.2026
Pharma

The Russian pharmaceutical manufacturer PFK "Renewal", operating under the Renewal brand, has commissioned a new production facility for the production of vital and essential medicines (VED) in the Novosibirsk region. The area of the complex exceeds 18.1 thousand square meters, and the design capacity reaches 100 million packages of finished products annually.

23.09.2026
Pharma

"VERTEX" is completing the commissioning of a blister-cardboard line with double-sided aluminum packaging, unique for its capacities. The new machine will become the tenth blister line of the enterprise and will allow to produce about 260 thousand packages by the end of 2026.

21.09.2026
Pharma

""""On Moscow Industry Day, Sergei Sobyanin opened a new production complex "Generium-Next" (GC "Farmstandart") at the Alabushevo site. The company will produce genetically engineered drugs for orphan and socially significant diseases for 8.5 billion rubles.

18.09.2026
Pharma

""PSK Pharma" company has completed a major project to modernize the production site of capsules with powder for inhalation at its own enterprise in the "Dubna" special economic zone. Investments exceeded 1 billion rubles, which made it possible to double the capacity of the line — from 80 to 160 thousand capsules per hour — and purchase new analytical and tablet equipment.

17.09.2026
Pharma

Pharmaceutical manufacturer "Nizhpharm" announced the launch of a new line of packaging and packaging of soft dosage forms. The volume of investments in the project amounted to 158 million rubles, the maximum speed of the equipment reaches 270 packages per minute, which will increase production by 50%.

15.09.2026
Pharma

Gerresheimer, a German company specializing in glass, specialty glass, and plastic packaging for the pharmaceutical, cosmetic, and food industries, announced the commissioning of a new plant in Zhenjiang, China.

27.07.2026
PharmaTECH Kazakhstan 2026
Pharma

The PharmaTECH Kazakhstan exhibition, "Equipment, Raw Materials, and Technologies for the Pharmaceutical Industry," will take place from May 20 to 22, 2026, in Almaty.

21.05.2026